Variation in the utilization of antiarrhythmic drugs in patients with new-onset atrial fibrillation

被引：32
|
作者：
Zimetbaum, P [1 ]
Ho, KKL
Olshansky, B
Hadjis, T
Lemery, R
Friedman, PA
Cannom, DS
Chen, XH
Josephson, ME
机构：
[1] Beth Israel Deaconess Med Ctr, Div Cardiol, Dept Med, Boston, MA 02215 USA
[2] Harvard Clin Res Inst, Boston, MA USA
[3] Univ Iowa, Iowa City, IA USA
[4] McGill Univ, Montreal Gen Hosp, Montreal, PQ H3G 1A4, Canada
[5] Univ Ottawa, Inst Heart, Ottawa, ON, Canada
[6] Mayo Clin, Rochester, MN USA
[7] Good Samaritan Hosp, Los Angeles, CA USA
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 2003年 / 91卷 / 01期
关键词：
D O I：
10.1016/S0002-9149(02)03004-7
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
This registry of new-onset atrial fibrillation demonstrated significant variation in the utilization of antiarrhythmic drugs that was largely related to the specialty of the treating physician..
引用
收藏
页码：81 / +
页数：4
相关论文
共 50 条
  • [21] Triggers for new-onset atrial fibrillation in critically ill patients
    Bedford, Jonathan P.
    Ede, Jody
    Watkinson, Peter J.
    [J]. INTENSIVE AND CRITICAL CARE NURSING, 2021, 67
  • [22] Predictors of new-onset atrial fibrillation in geriatric trauma patients
    Marco, Catherine A.
    Lynde, Jennifer
    Nelson, Blake
    Madden, Joshua
    Schaefer, Adam
    Hardman, Claire
    McCarthy, Mary
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF EMERGENCY PHYSICIANS OPEN, 2020, 1 (02) : 102 - 106
  • [23] Risk of new-onset atrial fibrillation in patients undergoing hemodialysis
    Huang, C. -C.
    Chan, W. -L.
    Chen, Y. -C.
    Chen, T. -J.
    Chung, C. -M.
    Huang, P. -H.
    Lin, S. J.
    Chen, J. -W.
    Leu, H. -B.
    [J]. EUROPEAN HEART JOURNAL, 2012, 33 : 374 - 374
  • [24] Oral antiarrhythmic drugs in converting recent onset atrial fibrillation
    Deneer, VHM
    Borgh, MBI
    Kingma, JH
    Lie-A-Huen, L
    Brouwers, JRBJ
    [J]. PHARMACY WORLD & SCIENCE, 2004, 26 (02): : 66 - 78
  • [25] Oral antiarrhythmic drugs in converting recent onset atrial fibrillation
    Vera H.M. Deneer
    Marieke B.I. Borgh
    J. Herre Kingma
    Loraine Lie-A-Huen
    Jacobus R.B.J. Brouwers
    [J]. Pharmacy World and Science, 2004, 26 : 66 - 78
  • [26] New-onset atrial fibrillation after atrial ischemia
    Kondo, Yusuke
    Kobayashi, Yoshio
    [J]. JOURNAL OF ARRHYTHMIA, 2019, 35 (06) : 863 - 864
  • [27] Meta-Analysis of New-Onset Atrial Fibrillation Versus No History of Atrial Fibrillation in Patients With
    Shah, Kuldeep B.
    Saado, Jonathan
    Kerwin, Matthew
    Mazimba, Sula
    Kwon, Younghoon
    Mangrum, James Michael
    Salerno, Michael
    Haines, David E.
    Mehta, Nishaki K.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2022, 164 : 57 - 63
  • [28] Impact of the metabolic syndrome on atrial size in patients with new-onset atrial fibrillation
    Nicolaou, Vasilios N.
    Papadakis, John E.
    Karatzis, Emmanouil N.
    Dermitzaki, Sofia I.
    Tsakiris, Alexandros K.
    Skoufas, Panagiotis D.
    [J]. ANGIOLOGY, 2007, 58 (01) : 21 - 25
  • [29] Obesity and the risk of new-onset atrial fibrillation
    Wang, TJ
    Parise, H
    Levy, D
    Dagostino, RB
    Wolf, PA
    Vasan, RS
    Benjamin, EJ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (20): : 2471 - 2477
  • [30] Antiarrhythmic drugs for atrial fibrillation
    Marinelli, Alessandro
    Capucci, Alessandro
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (08) : 1201 - 1215
12345